Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids
Top Cited Papers
- 2 October 2007
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (40), 15858-15863
- https://doi.org/10.1073/pnas.0707413104
Abstract
Airway inflammation and epithelial remodeling are two key features of asthma. IL-13 and other cytokines produced during T helper type 2 cell-driven allergic inflammation contribute to airway epithelial goblet cell metaplasia and may alter epithelial-mesenchymal signaling, leading to increased subepithelial fibrosis or hyperplasia of smooth muscle. The beneficial effects of corticosteroids in asthma could relate to their ability to directly or indirectly decrease epithelial cell activation by inflammatory cells and cytokines. To identify markers of epithelial cell dysfunction and the effects of corticosteroids on epithelial cells in asthma, we studied airway epithelial cells collected from asthmatic subjects enrolled in a randomized controlled trial of inhaled corticosteroids, from healthy subjects and from smokers (disease control). By using gene expression microarrays, we found that chloride channel, calcium-activated, family member 1 (CLCA1), periostin, and serine peptidase inhibitor, clade B (ovalbumin), member 2 (serpinB2) were up-regulated in asthma but not in smokers. Corticosteroid treatment down-regulated expression of these three genes and markedly up-regulated expression of FK506-binding protein 51 (FKBP51). Whereas high baseline expression of CLCA1, periostin, and serpinB2 was associated with a good clinical response to corticosteroids, high expression of FKBP51 was associated with a poor response. By using airway epithelial cells in culture, we found that IL-13 increased expression of CLCA1, periostin, and serpinB2, an effect that was suppressed by corticosteroids. Corticosteroids also induced expression of FKBP51. Taken together, our findings show that airway epithelial cells in asthma have a distinct activation profile and identify direct and cell-autonomous effects of corticosteroid treatment on airway epithelial cells that relate to treatment responses and can now be the focus of specific mechanistic studies.Keywords
This publication has 51 references indexed in Scilit:
- Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular RemodelingCirculation Research, 2007
- IL-13 and Epidermal Growth Factor Receptor Have Critical but Distinct Roles in Epithelial Cell Mucin ProductionAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissuesJournal of Cellular Biochemistry, 2007
- Mechanisms of airway hyperresponsivenessJournal of Allergy and Clinical Immunology, 2006
- Genetic polymorphisms at FCER1B and PAI‐1 and asthma susceptibilityClinical and Experimental Allergy, 2006
- The undecided serpinThe FEBS Journal, 2005
- The immunogenetics of asthma and eczema: a new focus on the epitheliumNature Reviews Immunology, 2004
- Epithelial-Mesenchymal Communication in the Pathogenesis of Chronic AsthmaProceedings of the American Thoracic Society, 2004
- PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma modelBiochemical and Biophysical Research Communications, 2002
- Polymorphism 4G/5G in the plasminogen activator inhibitor‐1 (PAI‐1) gene is associated with IgE‐mediated allergic diseases and asthma in the Czech populationAllergy, 2002